Ganymed Pharmaceuticals

Valuation $1B

About Ganymed Pharmaceuticals

Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.
Headquarters Ganymed Pharmaceuticals, Mainz
Founded 2001-01-01
Industry Biopharma, Biotechnology, Pharmaceutical
Last Funding Type Series E
Valuation 1
Total Funding $212.70 million dollars
IPO Status Private

Financial

Funding Rounds 5
Number of Lead Investors 3
Total Funding Amount  $212.70 million dollars
Number of Investors 8

Related Angels

Daniel Gutenberg
View profile